Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miltiorrhiza polyphenol acid plus decompressive craniectomy for large-area cerebral infarction
ChiCTR2500111768Phase 4Not yet recruiting
- Sponsor
- Tangshan Gongren Hospital
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of salvia miltiorrhiza polyphenolic acid in brain infarction (2 arms), sponsored by Tangshan Gongren Hospital. Primary endpoint: NIHSS score. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
salvia miltiorrhiza polyphenolic acid
03
Conditions
brain infarction
Beyond the preview
Go deeper on ChiCTR2500111768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500111768.